© Copyright 2026 American Medical Association. All rights reserved.
Extensive progressive retinopathy of a preterm infant, commonly known as retinopathy of prematurity (ROP), is a serious condition that affects premature infants, particularly those born before 37 weeks of gestation. This condition is characterized by abnormal development of retinal blood vessels, which can lead to severe vision impairment or even blindness if not treated promptly. The treatment for ROP involves either photocoagulation or cryotherapy, which are performed in one or more sessions depending on the severity of the condition. Photocoagulation utilizes laser technology to target and destroy abnormal blood vessels, while cryotherapy involves freezing the affected areas of the retina. The procedure is typically performed on infants from birth up to one year of age, with a focus on those who are particularly vulnerable, such as those born at less than 31 weeks gestation and weighing less than 1250 grams (2.75 pounds) at birth. The goal of these treatments is to halt the progression of the disease by addressing the abnormal vascularization in the retina, thereby preserving the infant's vision and preventing further complications associated with ROP.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.